[1] |
JIA Yinyin, ZHANG Caishu, ZHOU Ying, LIU Li, GENG Ying, WEI Ningyi, NIU Sijing, CHEN Hua, XU Hui.
Evaluation methods for aerodynamic particle size distribution of fine particles in inhaled products
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 141-146.
|
[2] |
LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo.
Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
|
[3] |
FANG Zhie, LI Chengxian, BAI Zhaofang, ZHAO Xu, WANG Jiabo, XIAO Xiaohe.
Investigation of objectivity in the relationship between aristolochic acid and hepatocellular carcinoma
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 20-24.
|
[4] |
PAN Zhemin, XU Sheng, ZHENG Yi, CHEN Chenxin, LIU Yongmei, ZHANG Pengpeng, YE Xiaofei, HE Jia.
Comparison of likelihood ratio tests in post-marketing safety surveillance
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 655-660.
|
[5] |
WANG Zhao, ZHAO Jianfeng, YU Xinlan, JIN Hongyu, MA Shuangcheng.
Radiation screening of Chaihu Shugan pills via photostimulated luminescence
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 514-518.
|
[6] |
CAI Yuluo, GUO Jiahui, Wang Xinguo, TIAN Yilong, WANG Meng, NIU Liying, LI Junshan.
Research progress in Yi medicine Valeriana jatamans and predictive analysis of related quality markers
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 348-352.
|
[7] |
WANG Guoying, ZHOU Gang, WANG Qin, JI Ziwei, NING Xiao, CUI Li.
Analysis of impurity spectra and quality control of betahistine hydrochloride injection based on HPLC-QE-MS technology
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1332-1338.
|
[8] |
HAO Gang, HAN Feng, ZHOU Gang, WU Xing, YAN Hao, LI Xuyang, HOU Hailing, NING Xiao, CUI Li.
Methodological study of adenosylcobalamin bacterial endotoxin examination for injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1351-1356.
|
[9] |
WANG Zhao, LIU Yue, ZAN Ke, LI Hailiang, JIN Hongyu, MA Shuangcheng.
Preliminary study on extraction technology of tea extract used for Xinnaojian preparation
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1362-1367.
|
[10] |
TAN Liyuan, CAI Tong, WANG Yan.
Research progress in quantitative analysis methods for chemical reference substances
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1209-1216.
|
[11] |
LI Hailiang, LI Yaolei, WANG Zhao, ZAN Ke, LIU Lina, JIN Hongyu, MA Shuangcheng.
Research progress in error sources and control methods of mycotoxin detection in traditional Chinese medicine
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1184-1188.
|
[12] |
LIU Bo, GUO Yunxiao, LIU Lisha, FAN Huihong.
Research progress in key technologies for quality control of snake venom hemocoagulase drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1195-1200.
|
[13] |
PAN Xuejiao, SHEN Lingzhi, LIANG Hui, TANG Xuewen, FU Jian, DING Linling, LYU Huakun.
Incidence and monitoring of AEFI of EV71 vaccine in Zhejiang province
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 897-899.
|
[14] |
HUANG Lu, LIU Bo, WANG Yan, FAN Huihong, ZHANG Qingsheng.
Research progress in quality control of nucleoside antiviral drugs
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 692-696.
|
[15] |
YANG Jingfan, XU Lu, CHEN Suiqing.
Textual research of the toxic herb Kansui Radix
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 372-375.
|